Click to view our statement on Accessibility

People

Our people are our most valuable asset and their quality, creativity, and dedication are indispensable to our success.

Search People

Latest News About Our People

View All News
09 October 2024 In the News

Jason Mehta Weighs in on SEC Settlements, Clinical Research Fraud

Foley & Lardner LLP partner Jason Mehta commented on a recent health care litigation settlement with the U.S. Securities and Exchange Commission in the Clinical Trials Arena article, “Cassava Sciences: Phase III trials storm ahead amid controversy.”
08 October 2024 In the News

John Strom Assesses BIOSECURE ACT – 'Going to be tough to navigate'

Foley & Lardner LLP special counsel John Strom shared insight on the potential impact of the BIOSECURE ACT in the BioSpaces article, "WuXi Biologics Faces Uncertain Future in the U.S. After BIOSECURE Blow."
08 October 2024 In the News

Anil Shankar Shares Insight on Proposition 34, Impact to 340B Program

Foley & Lardner LLP partner Anil Shankar offered insight on California's Proposition 34, a ballot measure this election season, in the KCRW article, "Confused on Prop 34? It’s about the politics of rent control."